文献速递糖尿病

糖尿病相关钾通道TALK-2调控人β细胞内质网钙处理并影响胰岛素分泌

The diabetes-associated K+ channel TALK-2 controls human beta cell endoplasmic reticulum Ca2+ handling, which promotes basal insulin release and limits glucose-stimulated insulin secretion.
PubMed 文献 · Diabetologia · 2026-02-25

该研究探讨双孔钾通道TALK-2(由KCNK17编码)对人β细胞钙稳态和胰岛素分泌的调控。通过免疫荧光定位及在诱导细胞系和原代人β细胞中shRNA敲低TALK-2,发现TALK-2定位于质膜和内质网膜,加速内质网钙释放、减少钙储存并升高基础胞质钙;敲低TALK-2则减少基础胰岛素分泌并增强葡萄糖刺激的胰岛素分泌。结论提示TALK-2通过增强内质网钙漏抑制葡萄糖刺激的钙内流和胰岛素分泌。

要点

  • TALK-2定位于人β细胞质膜和内质网膜并形成功能性通道。
  • TALK-2加速内质网钙释放、减少钙储存并升高基础胞质钙。
  • 敲低TALK-2降低基础胰岛素分泌但增强葡萄糖刺激的胰岛素分泌。

核心结论

  • TALK-2在人β细胞内质网膜上增强钙释放的电驱动力,减少葡萄糖刺激的钙内流并限制葡萄糖刺激的胰岛素分泌。
  • TALK-2介导的内质网钙漏增加可能通过升高胞质钙增强基础胰岛素分泌。
  • KCNK17多态性增加TALK-2活性或表达可能通过削弱β细胞葡萄糖刺激钙内流、限制GSIS、促进内质网钙漏和升高基础胰岛素分泌增加2型糖尿病风险。

研究设计与样本

  • 研究采用免疫荧光染色及TALK-2-GFP构建体与胞内标志物共表达评估TALK-2定位。
  • 在TALK-2可诱导细胞系和/或原代人β细胞中,通过腺病毒介导的shRNA敲低TALK-2或 scramble shRNA,测量胞质钙、内质网钙、内质网膜电位、钾电流和胰岛素分泌。

主要发现

  • TALK-2蛋白定位于质膜和内质网膜,并在内质网膜上形成功能性通道。
  • 表达TALK-2的细胞内质网钙释放斜率 vs 对照为14.8 ± 0.7 vs 8.9 ± 1.3(mean ± SE),内质网钙储存振幅降低25 ± 5%,基础相对胞质钙增加12 ± 2%。
  • 表达TALK-2的细胞内质网钙释放后内质网膜超极化减弱,ASAP3ER振幅降低20 ± 0.8%。
  • 在人β细胞中,TALK-2敲低使内质网钙储存从对照的2.65 ± 0.14增至2.30 ± 0.12(减少钙漏)。
  • TALK-2敲低在正常血糖条件下降低β细胞胞质钙(2.88 ± 0.36 vs 对照3.16 ± 0.36),在高血糖条件下增加钙内流(4.07 ± 0.55 vs 对照3.45 ± 0.48)。

临床怎么用

  • TALK-2可能成为调节β细胞基础与葡萄糖刺激胰岛素分泌平衡的潜在靶点。
  • KCNK17表达或功能增益可能提示2型糖尿病风险增加,需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The two-pore domain K+ channel TWIK1-related alkalinisation-activated K+ channel 2 (TALK-2) is encoded by KCNK17, which is one of the most abundant beta cell K+ channel transcripts that also shows high islet expression specificity. Polymorphisms that increase islet KNCK17 expression or result in TALK-2 gain-of-function are associated with a predisposition for developing type 2 diabetes. However, there is a gap in knowledge of the beta cell function(s) of TALK-2. As K+ channels typically control beta cell Ca2+ handling, we aimed to examine the TALK-2 channel control of beta cell Ca2+ homeostasis and the resulting impact on insulin secretion. METHODS: Localisation of TALK-2 was evaluated with immunofluorescent staining as well as TALK-2-GFP construct co-expressed with intracellular markers. TALK-2 function was evaluated by measuring changes in cytoplasmic Ca2+ (Ca2+C), endoplasmic reticulum Ca2+ (Ca2+ER), ER membrane potential (Vm), K+ currents and insulin secretion in a TALK-2 inducible cell line and/or primary human beta cells with adenoviral-mediated shRNA knockdown (KD) of TALK-2 or scramble shRNA. RESULTS: TALK-2 protein localised to the plasma membrane and ER membrane, and formed functional channels on the ER membrane. Ca2+ER release was accelerated by TALK-2 (slope for TALK-2-expressing cells vs controls: 14.8 ± 0.7 vs 8.9 ± 1.3, respectively, shown as mean ± SE), which reduced Ca2+ER storage (ΔCa2+ER amplitude: TALK-2-expressing cells reduced by 25 ± 5%) and increased basal relative Ca2+C (fold increase by 12 ± 2%). Furthermore, TALK-2 diminished ER membrane hyperpolarisation following Ca2+ER release (Accelerated Sensor of Action Potentials [ASAP3ER] amplitude decreased by 20 ± 0.8% in TALK-2-expressing cells), suggesting that TALK-2 strengthens the electrical driving force for Ca2+ER leak. In human beta cells, TALK-2-KD increased Ca2+ER stores by reducing Ca2+ER leak (2.30 ± 0.12 vs controls 2.65 ± 0.14). Moreover, TALK-2-KD reduced beta cell Ca2+C at euglycaemic conditions (2.88 ± 0.36 vs controls 3.16 ± 0.36) and increased beta cell Ca2+C influx in response to hyperglycaemic conditions (4.07 ± 0.55 vs controls 3.45 ± 0.48). Human pseudoislets with beta cell-specific TALK-2-KD displayed reduced basal insulin secretion (0.266 ± 0.065 vs controls 0.432 ± 0.073) and enhanced glucose-stimulated insulin secretion (GSIS; 85.01 ± 13.96 vs controls 42.53 ± 5.52). CONCLUSIONS/INTERPRETATION: These data support the notion that TALK-2 functions on the human beta cell ER membrane to increase the electrical driving force for beta cell Ca2+ER release, reduces glucose-stimulated Ca2+ influx and limits GSIS. Furthermore, TALK-2-mediated amplification of Ca2+ER leak likely enhances basal insulin secretion by increasing Ca2+C. Therefore, polymorphisms in KCNK17 that increase TALK-2 activity or expression would be predicted to increase type 2 diabetes risk by blunting beta cell glucose-stimulated Ca2+ influx, limiting GSIS, promoting Ca2+ER leak and elevating basal insulin secretion.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Dobson JR, Dadi PK, Dickerson MT, et al. The diabetes-associated K+ channel TALK-2 controls human beta cell endoplasmic reticulum Ca2+ handling, which promotes basal insulin release and limits glucose-stimulated insulin secretion. Diabetologia. 2026. PMID: 41739147. doi:10.1007/s00125-026-06683-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。